The emerging role of TLR2/4 as immuno-metabolic receptors points to key involvement of TLR/IL-1R/MyD88 pathway in obesity/type-2 diabetes (T2D). The gene discussed is TLR2; the disease is obesity due to melanocortin 4 receptor deficiency.